• STUDIES
    Participation is open to worldwide institutions.
    Read More
  • MEETINGS
    Since 1998, an Annual Meeting of the IELSG investigators has been regularly held.
    Read More
  • NEWSLETTER
    The IELSG Newsletter informs about studies, meetings and other research activities.
    Read More
  • PUBLICATIONS
    The results are presented to major congresses and published into peer-reviewed journals.
    Read More

Fighting cancer through research. You can support us by making a donation, however large or small.

Support Us

LATEST NEWS


ONGOING STUDIES

  • IELSG50
    IELSG50 Pembrolizumab and radiotherapy for previously untreated patients with limited-stage NK/T cell lymphoma who are not eligible for chemotherapy Participants required: 30… Read more: IELSG50
  • IELSG45
    IELSG45 Randomized phase II trial on fitness- and comorbidity-tailored treatment in elderly patients with newly diagnosed primary CNS lymphoma (FIORELLA Trial) Participants… Read more: IELSG45
  • IELSG44
    IELSG44 FDG-PET evaluation for marginal zone lymphoma and its prognostic role: an international multicenter retrospective analysis (PIMENTO) Participants required: 350 Investigator responsible(s):… Read more: IELSG44

LATEST NEWSLETTER

PUBLICATIONS

Top